PBYI Puma Biotechnology Inc - Common Stock
$9.41
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026
52W Range
$4–$10
98% of range
Analyst Rating
HOLD
6 analysts
Price Target
$6
P/E (TTM)
15.6
ROE
26.5%
Net Profit Margin
13.6%
About Puma Biotechnology Inc - Common Stock Company overview from Wikipedia
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Read more
Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.
Creation
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was sold to Johnson & Johnson in 2009. Auerbach brought many Cougar employees with him after founding Puma in 2010.
Funding for development
In August 2011 Puma licensed two drug candidates from Pfizer: neratinib (PB272) and an analog (PB357) to serve as a backup candidate.
As part of an approximately $60 million financing round in October 2011, Puma entered into a reverse merger with the shell company Innovative Acquisitions Corp., formed in 2007. In April 2012 the company's stock began trading over the counter. In October 2012 the company raised around $138 million and its shares were listed on the New York Stock Exchange.
In 2016 Puma discovered that Robert Gadimian, senior director of regulatory affairs, had twice bought and sold stock based on his knowledge of unpublished clinical trial results; Puma quickly fired him after conducting an internal investigation and reported the insider trading to the SEC.
Approval and licensing of neratinib
In March 2016 Puma held a pre-NDA meeting with the FDA in which the FDA raised concerns about the design and conduct of clinical trials that Puma had run and recommended that Puma not file the NDA with that data.
Puma did file the NDA, and in May 2017 an FDA review panel recommended that the FDA approve neratinib but raised concerns that the intended use was too broad and should be limited to people with specific mutations. The FDA's briefing document to the panel had raised concerns about the marginal benefit of the drug and the side effects. In July 2017 the FDA approved neratinib for use in preventing the return of breast cancer after treatment that included trastuzumab and without any need for genetic testing, and with warnings about the risk of severe diarrhea. U.S. sales of neratinib totaled $200.5 million in 2018.
In January 2018 an EMA committee gave a negative review to neratinib. In June 2018 this same EMA committee recommended the approval of neratinib, which received European Commission (EC) approval in September 2018.
In 2019 Puma licensed commercialization rights in Europe and part of Africa to Pierre Fabre for an upfront payment of $60 million and milestone payments that could reach $345 million. Previously, Puma licensed rights in Greater China to CANbrdige Life Sciences, rights in Israel to Medison Pharma, rights in Canada to Knight Therapeutics, rights in South East Asian to Specialised Therapeutics and rights in Latin America to Pint Pharma.
== References ==
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
PBYI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$9.41
Market Cap
$479M
P/E (TTM)
15.6
EPS (TTM)
$0.61
Revenue (TTM)
$228M
Div Yield
—
ROE
26.5%
Debt/Equity
0.2
52W Range
$4 – $10
PBYI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$228M
2017-12-31
→
2025-12-31
EPS
$0.61
2020-12-31
→
2025-12-31
Free Cash Flow
$42M
2016-12-31
→
2025-12-31
Margins
13.6%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
PBYI
Peer Median
P/E (TTM)
15.6
17.4
P/S (TTM)
2.1
52.3
P/B
3.7
4.8
EV / EBITDA
10.8
—
Price / FCF
11.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
PBYI
Peer Median
Operating Margin
16.3%
—
Net Profit Margin
13.6%
-670.1%
ROA
14.5%
-41.1%
ROE
26.5%
-52.6%
ROIC
21.2%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
PBYI
Peer Median
Debt / Equity
0.2
—
Current Ratio
2.0
7.7
Quick Ratio
1.9
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
PBYI
Peer Median
Revenue YoY
-0.91%
—
Revenue CAGR 3Y
0.05%
—
Revenue CAGR 5Y
0.29%
—
EPS YoY
-1.6%
—
Net Income YoY
2.8%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
PBYI
Peer Median
PBYI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
SELL
6 analysts
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
12-Month Price Target
1 analysts · 2026-08-18
Low
$6.00
High
$6.00
Median target
$6.00
-36.2%
Mean target
$6.00
-36.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.07%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $0.16 | $0.04 | 0.12% |
| March 31, 2026 | $-0.07 | $-0.13 | 0.06% |
| Dec. 31, 2025 | $0.26 | $0.23 | 0.03% |
| Sept. 30, 2025 | $0.17 | $0.05 | 0.12% |
| June 30, 2025 | $0.12 | $0.10 | 0.02% |
| March 31, 2025 | $0.06 | $-0.02 | 0.08% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Cost of Revenue | $58M | $64M | $63M | $55M | $64M | $39M | $37M | $35M | $6M | |
| R&D Expense | · | · | · | · | $72M | $98M | $133M | $165M | $208M | |
| SG&A Expense | $71M | $80M | $90M | $90M | $116M | $118M | $142M | $146M | $107M | |
| Operating Expenses | $191M | $200M | $203M | $204M | $252M | $256M | $311M | $346M | $320M | |
| Operating Income | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M | |
| Interest Expense | · | · | $13M | $12M | $13M | $14M | $15M | $11M | $720.0K | |
| Interest Income | $4M | $5M | $3M | $813.0K | $160.0K | $489.0K | $3M | $2M | $1M | |
| Other Non-op | $1M | $862.0K | $759.0K | $-28.0K | $292.0K | $367.0K | $128.0K | $-714.0K | $-101.0K | |
| Pretax Income | $36M | $24M | $23M | $457.0K | $-29M | $-60M | $-76M | $-114M | · | |
| Income Tax | $5M | $-6M | $1M | $455.0K | $324.0K | $207.0K | $53.0K | $17.0K | $0 | |
| Net Income | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| EPS (Basic) | $0.62 | $0.62 | $0.46 | $0.00 | $-0.72 | $-1.52 | $-75595.00 | · | · | |
| EPS (Diluted) | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 | $-1.52 | · | · | · | |
| Shares (Basic) | 50,011,485 | 48,648,701 | 47,134,331 | 44,674,501 | 40,638,852 | 39,576,107 | · | · | · | |
| Shares (Diluted) | 50,653,283 | 49,100,433 | 47,550,852 | 44,929,998 | 40,638,852 | 39,576,107 | · | · | · | |
| EBITDA | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M |
Balance Sheet 26
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $69M | $85M | $76M | $63M | $85M | $60M | $108M | $82M | |
| Short-term Investments | $68M | $32M | $11M | $5M | $19M | $8M | $52M | $57M | · | |
| Receivables | $54M | $32M | $48M | $40M | $33M | $26M | $29M | $21M | $10M | |
| Inventory | $6M | $9M | $7M | $5M | $7M | $3M | $3M | $3M | $2M | |
| Prepaid Expense | $4M | $6M | $4M | $6M | $9M | $11M | $13M | $12M | $13M | |
| Other Current Assets | $256.0K | $91.0K | $912.0K | $2M | $447.0K | $4M | $323.0K | $2M | · | |
| Current Assets | $163M | $148M | $156M | $134M | $140M | $146M | $166M | $203M | $106M | |
| PP&E (Net) | $187.0K | $515.0K | $855.0K | $1M | $2M | $2M | $3M | $4M | $4M | |
| PP&E (Gross) | $5M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Accum. Depreciation | $5M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | |
| Intangibles | $41M | $51M | $61M | $71M | $66M | $74M | $40M | $44M | $48M | |
| Total Assets | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Accounts Payable | $5M | $6M | $7M | $6M | $11M | $12M | $19M | $21M | $28M | |
| Accrued Liabilities | $50M | $37M | $53M | $53M | $93M | $61M | $69M | $46M | $31M | |
| Current Liabilities | $81M | $96M | $99M | $77M | $110M | $114M | $91M | $67M | $58M | |
| Capital Leases | $5M | $1M | $7M | $12M | $16M | $20M | $23M | · | · | |
| Other Non-current Liabilities | $0 | $121.0K | $121.0K | · | · | · | · | · | · | |
| Total Liabilities | $86M | $121M | $177M | $200M | $229M | $250M | $217M | $225M | $112M | |
| Long-term Debt | $23M | $68M | $102M | $102M | $102M | $84M | $95M | $152M | $48M | |
| Total Debt | $23M | $67M | $100M | $98M | $97M | $98M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.28B | $-1.31B | $-1.35B | $-1.37B | $-1.37B | $-1.34B | $-1.28B | $-1.20B | $-1.09B | |
| AOCI | $36.0K | $6.0K | $-4.0K | $0 | $-2.0K | $0 | $62.0K | $-12.0K | · | |
| Stockholders' Equity | $130M | $92M | $53M | $22M | $-2M | $-6M | $17M | $34M | $53M | |
| Liabilities + Equity | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Shares Outstanding | 50,408,023 | 49,105,834 | 47,646,787 | 46,345,660 | 41,175,507 | 40,086,387 | 39,203,304 | 38,325,037 | 37,594,851 |
Cash Flow 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $12M | $12M | $10M | $11M | $10M | $8M | $7M | $3M | |
| Stock-based Comp | $7M | $8M | $10M | $12M | $33M | $37M | $57M | $87M | $109M | |
| Deferred Tax | $3M | $-7M | $0 | $0 | · | · | · | · | · | |
| Amort. of Intangibles | $10M | $10M | $8M | $8M | $8M | $6M | $4M | $4M | $2M | |
| Operating Cash Flow | $42M | $39M | $27M | $-16M | $21M | $773.0K | $22M | $-24M | $-172M | |
| CapEx | $71.0K | $56.0K | $140.0K | $0 | $0 | $46.0K | $306.0K | $439.0K | $431.0K | |
| Investing Cash Flow | $-36M | $-20M | $-19M | $7M | $-11M | $33M | $5M | $-58M | $-15M | |
| Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Net Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Financing Cash Flow | $-45M | $-34M | $0 | $12M | $-32M | $-10M | $-67M | $108M | $75M | |
| Net Change in Cash | $-40M | $-15M | $8M | $4M | $-22M | $24M | $-40M | $27M | $-113M | |
| Taxes Paid | $1M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $42M | $39M | $27M | $-16M | $21M | · | · | $-25M | $-173M | |
| Levered FCF | · | · | $14M | $-16M | $8M | · | · | · | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| Net Margin | 13.6% | 13.1% | 9.2% | 0.00% | -11.5% | -26.7% | -27.8% | -45.2% | -1054.6% | |
| Pretax Margin | 15.7% | 10.5% | 9.6% | 0.20% | -11.4% | -26.6% | · | · | · | |
| EBITDA Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| ROA | 14.5% | 13.6% | 9.5% | 0.00% | -12.4% | -25.0% | -30.6% | -53.5% | -139.6% | |
| ROE | 26.5% | 37.1% | 46.8% | 0.01% | 435.8% | 1873.7% | -436.4% | -283.2% | -221.9% | |
| ROIC | 21.2% | 24.4% | 20.3% | 0.09% | 1.4% | -33.0% | · | · | · |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 | 1.3 | 1.8 | 3.0 | 1.8 | |
| Quick Ratio | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 | 1.0 | 1.5 | 2.8 | 1.6 | |
| Debt / Equity | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 | -16.5 | · | · | · | |
| LT Debt / Equity | 0.0 | 0.2 | 1.2 | 4.5 | -39.7 | -14.1 | · | · | · | |
| Interest Coverage | · | · | 2.4 | 2.0 | 0.1 | -2.2 | -2.6 | -8.6 | -406.1 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 0.1 | |
| Inventory Turnover | 8.2 | 8.2 | 10.8 | 9.5 | 12.1 | · | · | 14.9 | 5.5 | |
| Receivables Turnover | 5.3 | 5.8 | 5.3 | 6.3 | 8.7 | 8.3 | 11.0 | 16.5 | 5.7 |
Growth Rates 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.91% | -2.2% | 3.3% | -9.9% | 12.5% | · | · | · | · | |
| Revenue CAGR 3Y | 0.05% | -3.1% | 1.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.29% | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.6% | 37.8% | · | · | · | · | · | · | · | |
| Net Income YoY | 2.8% | 40.2% | 1079450.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 2396.3% | · | · | · | · | · | · | · | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Net Income TTM | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| Market Cap | $300M | $150M | $206M | $174M | $122M | $411M | $343M | $780M | $3.72B | |
| Enterprise Value | $225M | $116M | $210M | $191M | $137M | $416M | · | · | · | |
| P/E | 9.8 | 4.9 | 9.6 | · | -4.2 | -6.8 | · | · | · | |
| P/S | 1.3 | 0.6 | 0.9 | 0.8 | 0.5 | 1.8 | 1.3 | 3.1 | 134.2 | |
| P/B | 2.3 | 1.6 | 3.9 | 8.1 | -49.8 | -69.1 | 19.6 | 22.7 | 69.7 | |
| P / Tangible Book | 3.4 | 3.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 7.2 | 3.8 | 7.6 | -11.0 | 5.9 | 532.1 | 15.3 | -32.4 | -21.5 | |
| P / FCF | 7.2 | 3.9 | 7.7 | -11.0 | 5.9 | · | · | -31.8 | -21.5 | |
| EV / EBITDA | 6.0 | 3.7 | 6.4 | 8.1 | 106.1 | -13.7 | · | · | · | |
| EV / FCF | 5.4 | 3.0 | 7.8 | -12.1 | 6.6 | · | · | · | · | |
| EV / Revenue | 1.0 | 0.5 | 0.9 | 0.8 | 0.5 | 1.8 | · | · | · | |
| Earnings Yield | 10.2% | 20.3% | 10.4% | 0.00% | -23.7% | -14.8% | · | · | · |
Income Statement 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57M | $45M | $75M | $54M | $52M | $46M | $59M | $81M | $47M | $44M | $72M | $56M | $55M | $53M | $66M | $57M | |
| Cost of Revenue | $12M | $10M | $23M | $12M | $12M | $11M | $14M | $29M | $11M | $11M | $24M | $13M | $12M | $13M | $17M | $12M | |
| SG&A Expense | $18M | $18M | $18M | $17M | $18M | $18M | $17M | $17M | $25M | $22M | $20M | $23M | $24M | $22M | $25M | $24M | |
| Operating Expenses | $49M | $49M | $58M | $45M | $46M | $42M | $46M | $58M | $49M | $46M | $57M | $48M | $50M | $48M | $56M | $55M | |
| Operating Income | $8M | $-4M | $17M | $10M | $7M | $4M | $13M | $22M | $-2M | $-2M | $15M | $9M | $5M | $4M | $10M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $831.0K | $1M | $977.0K | $1M | $956.0K | $1M | $1M | $1M | $1M | $972.0K | $719.0K | $689.0K | $660.0K | $537.0K | $519.0K | $216.0K | |
| Other Non-op | $9.0K | $130.0K | $143.0K | $115.0K | $410.0K | $359.0K | $268.0K | $347.0K | $156.0K | $91.0K | $641.0K | $74.0K | $86.0K | $-42.0K | $-204.0K | $64.0K | |
| Pretax Income | $8M | $-3M | $17M | $9M | $6M | $3M | $12M | $21M | $-4M | $-5M | $13M | $6M | $2M | $2M | $-5M | $-293.0K | |
| Income Tax | · | · | · | · | · | · | $-7M | $291.0K | $378.0K | $220.0K | $536.0K | $213.0K | $187.0K | $147.0K | $294.0K | $67.0K | |
| Net Income | $8M | $-4M | $13M | $9M | $6M | $3M | $19M | $20M | $-5M | $-5M | $12M | $6M | $2M | $1M | $-6M | $-360.0K | |
| EPS (Basic) | $0.16 | $-0.07 | $0.26 | $0.18 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.26 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| EPS (Diluted) | $0.16 | $-0.07 | $0.26 | $0.17 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.25 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| Shares (Basic) | 50,939,946 | 50,845,130 | -99,623,885 | 50,339,456 | 49,700,217 | 49,595,697 | -96,841,433 | 49,008,464 | 48,292,414 | 48,189,256 | -93,781,152 | 47,520,338 | 46,759,062 | 46,636,083 | -88,159,871 | 45,567,739 | |
| Shares (Diluted) | 52,596,589 | 50,845,130 | -100,327,655 | 50,929,893 | 50,144,704 | 49,906,341 | -96,554,598 | 49,173,361 | 48,292,414 | 48,189,256 | -94,627,471 | 47,819,234 | 47,201,185 | 47,157,904 | -88,204,189 | 45,567,739 | |
| EBITDA | $8M | $-4M | · | $10M | $7M | · | · | $22M | $-2M | $-2M | · | $9M | $5M | $4M | · | $2M |
Balance Sheet 26
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $36M | $30M | $54M | $55M | $63M | $69M | $67M | $67M | $77M | · | $82M | $60M | $61M | · | $78M | |
| Short-term Investments | $57M | $65M | $68M | $41M | $41M | $30M | $32M | $29M | $30M | $30M | · | $3M | $14M | $10M | · | $0 | |
| Receivables | $34M | $26M | $54M | $34M | $26M | $25M | $32M | $55M | $28M | $25M | · | $29M | $31M | $31M | · | $28M | |
| Inventory | $13M | $9M | $6M | $9M | $9M | $9M | $9M | $3M | $9M | $7M | · | $6M | $8M | $4M | · | $5M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $4M | $5M | $6M | $3M | $3M | $4M | · | $4M | $5M | $5M | · | $7M | |
| Other Current Assets | $199.0K | $196.0K | $256.0K | $230.0K | $73.0K | $98.0K | $91.0K | $236.0K | $241.0K | $255.0K | · | $2M | $573.0K | $449.0K | · | $4M | |
| Current Assets | $145M | $142M | $163M | $144M | $137M | $133M | $148M | $157M | $138M | $143M | · | $125M | $119M | $112M | · | $122M | |
| PP&E (Net) | $103.0K | $124.0K | $187.0K | $305.0K | $388.0K | $474.0K | $515.0K | $601.0K | $680.0K | $757.0K | · | $907.0K | $977.0K | $1M | · | $1M | |
| PP&E (Gross) | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Accum. Depreciation | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $7M | |
| Intangibles | · | · | $41M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Accounts Payable | $3M | $8M | $5M | $6M | $5M | $6M | $6M | $8M | $14M | $9M | · | $5M | $8M | $9M | · | $15M | |
| Accrued Liabilities | $45M | $38M | $50M | $37M | $32M | $27M | $37M | $51M | $39M | $38M | · | $34M | $35M | $34M | · | $40M | |
| Current Liabilities | $50M | $60M | $81M | $83M | $79M | $87M | $96M | $110M | $104M | $98M | · | $67M | $60M | $48M | · | $60M | |
| Capital Leases | $4M | $5M | $5M | $5M | $0 | $0 | $1M | $3M | $4M | $6M | · | $8M | $10M | $11M | · | $13M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $121.0K | $121.0K | $121.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $54M | $64M | $86M | $88M | $90M | $99M | $121M | $150M | $156M | $163M | · | $165M | $170M | $170M | · | $177M | |
| Long-term Debt | $0 | $11M | $23M | $34M | $45M | $57M | $67M | $79M | $91M | $102M | · | $102M | $102M | $102M | · | $102M | |
| Total Debt | $0 | $11M | · | $34M | $45M | · | · | $78M | $89M | $100M | · | $99M | $99M | $99M | · | $98M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Retained Earnings | $-1.28B | $-1.29B | $-1.28B | $-1.30B | $-1.31B | $-1.31B | $-1.31B | $-1.33B | $-1.35B | $-1.35B | · | $-1.36B | $-1.36B | $-1.37B | · | $-1.36B | |
| AOCI | $-45.0K | $-31.0K | $36.0K | $19.0K | $-14.0K | $-11.0K | $6.0K | $26.0K | $-32.0K | $-26.0K | · | $-4.0K | $-6.0K | · | · | $0 | |
| Stockholders' Equity | $139M | $128M | $130M | $115M | $105M | $97M | $92M | $71M | $49M | $51M | $53M | $39M | $30M | $26M | $22M | $22M | |
| Liabilities + Equity | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Shares Outstanding | 51,102,687 | 50,879,204 | 50,408,023 | 50,384,274 | 49,892,725 | 49,615,174 | 49,105,834 | 49,067,348 | 48,460,120 | 48,214,663 | 47,646,787 | 47,542,790 | 46,947,153 | 46,663,599 | 46,345,660 | 45,608,814 |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $2M | $15M | $14M | $10M | $14M | $4M | $16M | $11M | $1M | $11M | $10M | $11M | $3M | $3M | $8M | $17M | |
| CapEx | $0 | $0 | $-36.0K | $26.0K | $20.0K | $61.0K | $16.0K | $20.0K | $20.0K | $0 | $45.0K | $27.0K | · | · | $0 | $0 | |
| Investing Cash Flow | $8M | $2M | $-27M | $506.0K | $-11M | $2M | $-2M | $259.0K | $703.0K | $-19M | $-8M | $11M | $-5M | $-17M | $-12M | $8M | |
| Financing Cash Flow | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $0 | $0 | $0 | $0 | $0 | $2M | $-53.0K | |
| Net Change in Cash | $-2M | $7M | $-24M | $-1M | $-8M | $-6M | $2M | $114.0K | $-10M | $-8M | $2M | $22M | $-1M | $-15M | $-2M | $25M | |
| Free Cash Flow | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| Net Margin | 14.5% | -8.4% | · | 16.2% | 11.2% | · | · | 25.2% | -9.6% | -11.0% | · | 10.3% | 3.9% | 2.6% | · | -0.63% | |
| Pretax Margin | 14.6% | -7.6% | · | 17.0% | 11.8% | · | · | 25.6% | -8.8% | -10.5% | · | 10.7% | 4.2% | 2.9% | · | -0.51% | |
| EBITDA Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| ROA | 4.2% | -1.9% | · | 4.2% | 2.9% | · | · | 9.6% | -2.2% | -2.4% | · | 2.9% | 1.1% | 0.71% | · | -0.17% | |
| ROE | 6.7% | -3.3% | · | 9.5% | 7.6% | · | · | 37.0% | -11.5% | -12.5% | · | 19.0% | 8.5% | 8.5% | · | -6.4% | |
| ROIC | · | · | · | · | · | · | · | 14.6% | -1.7% | -1.6% | · | 6.0% | 3.5% | 3.2% | · | 2.5% |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.4 | · | 1.7 | 1.7 | · | · | 1.4 | 1.3 | 1.5 | · | 1.9 | 2.0 | 2.3 | · | 2.0 | |
| Quick Ratio | 2.6 | 2.1 | · | 1.5 | 1.5 | · | · | 1.4 | 1.2 | 1.3 | · | 1.7 | 1.8 | 2.1 | · | 1.8 | |
| Debt / Equity | 0.0 | 0.1 | · | 0.3 | 0.4 | · | · | 1.1 | 1.8 | 2.0 | · | 2.6 | 3.3 | 3.8 | · | 4.4 | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.1 | · | · | 0.5 | 0.9 | 1.1 | · | 2.0 | 2.9 | 3.8 | · | 4.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -0.7 | · | 2.6 | 1.5 | 1.3 | · | 0.8 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.3 | · | · | 0.4 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 1.1 | 1.2 | · | 2.0 | 1.4 | · | · | 7.0 | 1.3 | 2.0 | · | 2.4 | 1.7 | 2.4 | · | 2.0 | |
| Receivables Turnover | 1.9 | 1.7 | · | 1.2 | 1.9 | · | · | 1.9 | 1.6 | 1.6 | · | 2.0 | 1.7 | 1.8 | · | 2.2 |
Valuation (TTM) 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $208M | $198M | · | $233M | $226M | $217M | · | $228M | $202M | $207M | · | $221M | $224M | $215M | · | $209M | |
| Net Income TTM | $19M | $14M | · | $38M | $25M | $14M | · | $17M | $-1M | $5M | · | $9M | $13M | $7M | · | $-39M | |
| Market Cap | $414M | $325M | · | $268M | $171M | · | · | $125M | $158M | $256M | · | $125M | $166M | $144M | · | $108M | |
| Enterprise Value | $321M | $235M | · | $207M | $120M | · | · | $106M | $150M | $248M | · | $139M | $190M | $172M | · | $128M | |
| P/E | 21.3 | 22.8 | · | 7.0 | 6.9 | 10.6 | · | 7.5 | -163.0 | 53.0 | · | 13.8 | 12.6 | 20.6 | · | -2.4 | |
| P/S | 2.0 | 1.6 | · | 1.1 | 0.8 | · | · | 0.6 | 0.8 | 1.2 | · | 0.6 | 0.7 | 0.7 | · | 0.5 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 1.6 | · | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Tangible Book | 3.0 | 2.5 | · | 2.3 | 1.6 | 1.5 | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Cash Flow | · | 21.1 | · | · | · | · | · | · | · | 22.7 | · | · | · | 54.6 | · | · | |
| P / FCF | · | 21.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 42.3 | -61.4 | · | 21.6 | 18.1 | · | · | 4.8 | -68.9 | -108.0 | · | 16.2 | 38.9 | 39.3 | · | 53.5 | |
| EV / FCF | · | 15.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 1.5 | 1.2 | · | 0.9 | 0.5 | · | · | 0.5 | 0.7 | 1.2 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | |
| Earnings Yield | 4.7% | 4.4% | · | 14.3% | 14.6% | 9.5% | · | 13.3% | -0.61% | 1.9% | · | 7.2% | 7.9% | 4.9% | · | -40.9% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $228M | $230M | $236M | $228M | $253M |
| Operating Margin % | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% |
| Net Income | $31M | $30M | $22M | $2.0K | $-29M |
| Diluted EPS | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 |
| Current Ratio | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 |
| Quick Ratio | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $42M | $39M | $27M | $-16M | $21M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 173 filers · $239.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (+2 vs prior Q) | 15 (-2 vs prior Q) | 56 (+1 vs prior Q) | 47 (+7 vs prior Q) | +4.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | $33,504,835 | 4,131,299 | 13.97% | Shares |
| VANGUARD GROUP INC | $21,011,306 | 3,531,312 | 8.76% | Shares |
| AMERICAN CENTURY COMPANIES INC | $18,815,168 | 2,319,996 | 7.85% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $14,891,687 | 1,836,213 | 6.21% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $14,887,065 | 1,835,643 | 6.21% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14,805,608 | 1,825,599 | 6.18% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $11,407,283 | 1,406,570 | 4.76% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $9,618,136 | 1,185,702 | 4.01% | Shares |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $9,113,880 | 1,123,783 | 3.80% | Shares |
| STATE STREET CORP | $7,722,058 | 952,165 | 3.22% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $7,082,082 | 873,253 | 2.95% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $6,420,006 | 791,616 | 2.68% | Shares |
| RITHOLTZ WEALTH MANAGEMENT | $6,080,862 | 749,798 | 2.54% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $5,214,292 | 642,946 | 2.17% | Shares |
| MILLENNIUM MANAGEMENT LLC | $4,884,166 | 602,240 | 2.04% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4,318,170 | 532,450 | 1.80% | Shares |
| GLOBEFLEX CAPITAL L P | $3,104,565 | 382,807 | 1.29% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2,506,850 | 309,106 | 1.05% | Shares |
| D. E. Shaw & Co., Inc. | $2,300,377 | 283,647 | 0.96% | Shares |
| Russell Investments Group, Ltd. | $2,207,323 | 272,173 | 0.92% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,182,158 | 269,070 | 0.91% | Shares |
| FEDERATED HERMES, INC. | $2,033,712 | 250,766 | 0.85% | Shares |
| Empowered Funds, LLC | $1,786,763 | 220,316 | 0.75% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $1,764,290 | 217,545 | 0.74% | Shares |
| GOLDMAN SACHS GROUP INC | $1,758,256 | 216,801 | 0.73% | Shares |
| FMR LLC | $1,708,274 | 210,638 | 0.71% | Shares |
| PRUDENTIAL FINANCIAL INC | $1,600,095 | 197,299 | 0.67% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,526,562 | 188,232 | 0.64% | Shares |
| Prospera Financial Services Inc | $1,287,530 | 158,762 | 0.54% | Shares |
| Haven Private, LLC | $1,203,913 | 148,448 | 0.50% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,140,161 | 140,587 | 0.48% | Shares |
| BlackRock, Inc. | $1,134,784 | 139,924 | 0.47% | Shares |
| FIRST TRUST ADVISORS LP | $1,055,970 | 130,206 | 0.44% | Shares |
| Bank of New York Mellon Corp | $1,048,964 | 129,342 | 0.44% | Shares |
| Round Rock Advisors LLC | $1,045,476 | 128,912 | 0.44% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,040,051 | 128,243 | 0.43% | Shares |
| STRS OHIO | $686,106 | 84,600 | 0.29% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $596,085 | 73,500 | 0.25% | Shares |
| Trexquant Investment LP | $585,729 | 72,223 | 0.24% | Shares |
| Vise Technologies, Inc. | $584,163 | 72,030 | 0.24% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $520,662 | 64,200 | 0.22% | Call option |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $497,000 | 61,255 | 0.21% | Shares |
| OpenArc Corporate Advisory, LLC | $482,472 | 59,491 | 0.20% | Shares |
| RHUMBLINE ADVISERS | $466,397 | 57,510 | 0.19% | Shares |
| TWO SIGMA ADVISERS, LP | $423,045 | 71,100 | 0.18% | Shares |
| D'Orazio & Associates, Inc. | $394,795 | 48,680 | 0.16% | Shares |
| Vanguard Global Advisers, LLC | $375,225 | 46,267 | 0.16% | Shares |
| DEUTSCHE BANK AG\ | $350,287 | 43,192 | 0.15% | Shares |
| Man Group plc | $336,614 | 41,506 | 0.14% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $333,240 | 41,090 | 0.14% | Shares |
| WINTON GROUP Ltd | $328,528 | 40,509 | 0.14% | Shares |
| XTX Topco Ltd | $326,801 | 40,296 | 0.14% | Shares |
| State of Wyoming | $323,046 | 39,833 | 0.13% | Shares |
| WELLS FARGO & COMPANY/MN | $304,977 | 37,605 | 0.13% | Shares |
| EntryPoint Capital, LLC | $303,200 | 37,386 | 0.13% | Shares |
| Baron Wealth Management LLC | $294,977 | 36,372 | 0.12% | Shares |
| Creative Planning | $289,827 | 35,737 | 0.12% | Shares |
| LPL Financial LLC | $280,095 | 34,537 | 0.12% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $279,673 | 34,485 | 0.12% | Shares |
| BANK OF AMERICA CORP /DE/ | $257,468 | 31,747 | 0.11% | Shares |
| Kathmere Capital Management, LLC | $252,805 | 31,172 | 0.11% | Shares |
| FRANKLIN RESOURCES INC | $242,165 | 29,860 | 0.10% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $236,731 | 29,190 | 0.10% | Shares |
| Y-Intercept (Hong Kong) Ltd | $212,660 | 26,222 | 0.09% | Shares |
| MARTINGALE ASSET MANAGEMENT L P | $205,703 | 25,364 | 0.09% | Shares |
| Metis Global Partners, LLC | $204,891 | 25,264 | 0.09% | Shares |
| MetLife Investment Management, LLC | $201,720 | 24,873 | 0.08% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195,451 | 24,100 | 0.08% | Put option |
| C2C Wealth Management, LLC | $191,558 | 23,620 | 0.08% | Shares |
| Nuveen, LLC | $187,982 | 23,179 | 0.08% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $174,754 | 21,548 | 0.07% | Shares |
| One Wealth Advisors, LLC | $170,951 | 21,079 | 0.07% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $165,306 | 20,383 | 0.07% | Shares |
| CITIGROUP INC | $154,990 | 19,111 | 0.06% | Shares |
| BAILARD, INC. | $146,791 | 18,100 | 0.06% | Shares |
| Invesco Ltd. | $142,493 | 17,570 | 0.06% | Shares |
| JANE STREET GROUP, LLC | $141,925 | 17,500 | 0.06% | Call option |
| Spark Investment Management LLC | $137,870 | 17,000 | 0.06% | Shares |
| MORGAN STANLEY | $137,416 | 16,944 | 0.06% | Shares |
| ALLIANCEBERNSTEIN L.P. | $136,490 | 21,360 | 0.06% | Shares |
| Brandywine Global Investment Management, LLC | $129,710 | 21,800 | 0.05% | Shares |
| Police & Firemen's Retirement System of New Jersey | $127,481 | 15,719 | 0.05% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $125,510 | 15,476 | 0.05% | Shares |
| Lido Advisors, LLC | $122,015 | 15,045 | 0.05% | Shares |
| Mariner, LLC | $120,593 | 14,869 | 0.05% | Shares |
| Caprock Group, LLC | $112,421 | 13,862 | 0.05% | Shares |
| PERKINS CAPITAL MANAGEMENT INC | $108,674 | 13,400 | 0.05% | Shares |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $107,960 | 13,312 | 0.05% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $105,624 | 13,203 | 0.04% | Shares |
| UBS Group AG | $99,923 | 12,321 | 0.04% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $97,774 | 12,056 | 0.04% | Shares |
| CWM, LLC | $97,531 | 15,263 | 0.04% | Shares |
| R Squared Ltd | $97,247 | 11,991 | 0.04% | Shares |
| Abel Hall, LLC | $93,427 | 11,520 | 0.04% | Shares |
| IEQ CAPITAL, LLC | $86,542 | 10,671 | 0.04% | Shares |
| Williams & Novak, LLC | $85,066 | 10,489 | 0.04% | Shares |
| Vanguard Personalized Indexing Management, LLC | $84,409 | 10,408 | 0.04% | Shares |
| Ethic Inc. | $83,290 | 10,270 | 0.03% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $83,136 | 10,251 | 0.03% | Shares |
| INTECH INVESTMENT MANAGEMENT LLC | $82,803 | 10,210 | 0.03% | Shares |
Company insiders 24 insiders · 10 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Alan H Auerbach | President and CEO | July 6, 2026 S | 7,261,671 | 0 | 1 | $-363,919 |
| Maximo F Nougues | Chief Financial Officer | July 6, 2026 S | 230,637 | 0 | 1 | $-77,528 |
| Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | July 6, 2026 S | 196,841 | 0 | 1 | $-69,880 |
| Alvin F Wong | Chief Scientific Officer | June 17, 2021 A | — | 0 | 0 | $0 |
| Richard Paul Bryce | Title of Reporting Person: Chief Medical and Scientific Officer | April 5, 2021 S | 121,662 | 0 | 0 | $0 |
| Jeffrey Jerome Ludwig | Chief Commercial Officer | Feb. 17, 2021 A | 36,069 | 0 | 0 | $0 |
| Steven Lo | Chief Commercial Officer | July 22, 2019 S | 19,557 | 0 | 0 | $0 |
| Charles R Eyler | Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer | Feb. 4, 2019 S | 31,957 | 0 | 0 | $0 |
| Robert Charnas | The Reporting Person is the Senior Vice President of Regulatory Affairs and Project Management of the Issuer. | Feb. 16, 2017 A | 26,453 | 0 | 0 | $0 |
| Richard Benton Phillips | The Reporting Person is the Interim Head of Regulatory Affairs, Quality Assurance and Pharmacovigilance of the Issuer. | April 15, 2016 A | — | 0 | 0 | $0 |
| Brian M Stuglik | Director | June 12, 2026 S | 113,858 | 0 | 1 | $-58,320 |
| Allison Dorval | Director | June 12, 2026 S | 90,780 | 0 | 1 | $-83,592 |
| Adrian Senderowicz | Director | June 12, 2026 S | 27,000 | 0 | 1 | $-194,400 |
| Troy Edward Wilson | Director | June 12, 2026 S | 59,750 | 0 | 1 | $-77,760 |
| Jay M Moyes | Director | June 12, 2026 S | 58,322 | 0 | 1 | $-158,840 |
| Alessandra Cesano | Director | June 11, 2026 A | 68,850 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Director | June 11, 2026 A | 81,000 | 0 | 0 | $0 |
| Ann Calby Miller | Director | June 15, 2021 A | 40,732 | 0 | 0 | $0 |
| Hugh O'Dowd | Director | June 9, 2020 A | 25,748 | 0 | 0 | $0 |
| Frank Zavrl | Director | June 9, 2020 A | 50,993 | 0 | 0 | $0 |
| Thomas Malley | Director | Dec. 15, 2014 A | 156,551 | 0 | 0 | $0 |
| Faraaz Siddiqi | — | Oct. 4, 2011 D | 0 | 0 | 0 | $0 |
| Kapil Munjal | — | Oct. 4, 2011 D | 0 | 0 | 0 | $0 |
| Robert Andrew Johnson | — | Oct. 4, 2011 D | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 7 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Alan H. Auerbach ×6 filings | Dec. 13, 2022 | — | Initial filing | — | SEC |
| Kapil Munjal 2) | Oct. 4, 2011 | — | Initial filing | — | SEC |
| Faraaz Siddiqi 2) | Oct. 4, 2011 | — | Initial filing | — | SEC |
| Robert Johnson 2) | Oct. 4, 2011 | — | Initial filing | — | SEC |
| Robert Johnson | Nov. 21, 2007 | — | Initial filing | — | SEC |
| Undisclosed reporting person | Nov. 19, 2007 | — | Initial filing | — | SEC |
| Faraaz Siddiqi | Nov. 19, 2007 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 36 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0.72% | 52,608 NS | April 30, 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.46% | 233,908 SH | Aug. 8, 2026 | Daily |
| IWC · iShares Trust | 0.08% | 150,797 SH | Aug. 8, 2026 | Daily |
| VFQY · VANGUARD WELLINGTON FUND | 0.06% | 34,260 SH | Aug. 8, 2026 | Daily |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.05% | 1,924,360 NS | May 31, 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 55,680 NS | May 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 2,746 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 95,559 NS | May 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 32,358 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.02% | 356,623 SH | Aug. 8, 2026 | Daily |
| BIB · ProShares Trust | 0.02% | 1,879 NS | May 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 55,064 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,153,241 SH | Aug. 8, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 19,123 NS | April 30, 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.01% | 16,014 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 254,380 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 166,672 NS | April 30, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.01% | 156,761 NS | April 30, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.01% | 82,003 NS | April 30, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 2,027 NS | May 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 3,611 NS | April 30, 2026 | N-PORT |
| EBI · RBB Fund Trust | 0.01% | 5,394 NS | May 31, 2026 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,585 NS | May 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.00% | 65,370 SH | Aug. 8, 2026 | Daily |
| URTY · ProShares Trust | 0.00% | 1,603 NS | May 31, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,071 NS | May 31, 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 34,919 NS | May 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 6,348 NS | April 30, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 40 NS | May 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 9,704 NS | April 30, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 15,090 NS | April 30, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 12,376 NS | April 30, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 446,899 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,343,121 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,680 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,979 SH | Aug. 8, 2026 | Daily |